Vaccinex reports Q4 results

Apr. 02, 2024 10:09 AM ETVaccinex, Inc. (VCNX) StockBy: Vansh Agarwal, SA News Editor
  • Vaccinex press release (NASDAQ:VCNX): Raised $17.9 million of new financing during Q4 2023 and Q1 2024.
  • Cash and cash equivalents and marketable securities on December 31, 2023, were $1.5 million.

Recommended For You

More Trending News

About VCNX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VCNX--
Vaccinex, Inc.